You have read all your free articles, to continue reading subscribe to read the rest of this content.
In a new collaborative study with a major global pharma company, Immunovia's blood-based testing platform, IMMray could differentiate healthy controls from non-small cell lung cancer (NSCLC) samples with a 95 % accuracy, reports the company. The study included 100 serum samples - 50 NSCLC and 5Already a subscriber Login You have read…
The company has purchased a minority stake in the German company iRT Systems, in order to improve its quality assurance (QA) offering to clinics and hospitals. For the past six years, iRT Systems has developed the Integral Quality Monitor (IQM) system in cooperation with Princess Margaret Cancer Already a subscriber…
Diamyd Medical has completed a new share issue with preferential rights for existing shareholders through which the company will receive proceeds of MSEK 22.1 before issue expenses. There has been substantial interest in the issue. Subscription applications totaling approximately MSEK 45.8 were rAlready a subscriber Login You have read all…
Dignitana is partnering with the organization known as CHILL, Cancer-related Hair Loss, International Leadership and Linkage, which was launched this past weekend at the 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer (MASCC), held in Washington, D.C. Led by six Already a subscriber Login You have…
